JOURNALS CANCER RESEARCH 2012

www.iospress.com IOS PRESS JOURNAL PROGRAM

All IOS Press journals are published online and in print

Visit www.iospress.com to: • Enter your subscription online • Check all subscription options including backfiles • Purchase articles on a pay-per-view basis • Obtain a free electronic sample copy • Scan tables of contents • Set up a journal alert • Find complete Instructions for Authors

Open Library® : Open Access at IOS Press

In addition to publishing work in traditional subscription journals, IOS Press offers the option to publish research with open access, i.e. free to use, download, circulate, and disseminate by everyone, wherever in the world, as long as proper attribution is given to the author and the original source. The Open Library® option is available to all authors and for all journals published by IOS Press.

IOS PRESS EBOOKS PROGRAM www.booksonline.iospress.com

• Place your order online for ebooks or hardcopy books • Browse tables of contents • Read abstracts and preliminary pages free of charge • Search by subject or book series • Buy single titles and gain immediate access • Become a member and gain full access to all titles JOURNALS

Analytical Cellular

Impact Factor: 4.169* Calculated based on Cellular Oncology articles published in 2007-2008

ISSN 2210-7177 (print) ISSN 2210-7185 (online)

Analytical Cellular Pathology focuses on the burgeoning applications of physical techniques to the study of cells, tissues and organs in disease to elucidate pathogenesis and further translational research, enhanced diagnosis or prognostication, as well as new and better therapies. Of particular relevance are studies that explore the ways that aberrant biochemical and molecular pathways are transduced into the physical processes that underlie pathogenesis.

The journal appeals to an audience of pathologists, cell biologists and biochemists, as well as biomedical engineers by focusing on new applications of the rapidly evolving array of technologies. Papers should be based on novel concepts, novel methodologies or the novel use of existing methodologies that contribute to the study of pathologic processes, rather than methodological details only. Approaches include tools such as biomedical photonics, surface resonance phenomena and impedance tomography, as well as new approaches for ultra-high resolution magnetic resonance, multispectral, hyperspectral and vibrational mode analysis and computational biology models. Hypothesis generating and hypothesis-testing observational studies are also welcome.

Editor-in-Chief Brief History Stanley Cohen, MD, University of Medicine & Dentistry of , Analytical Cellular New Jersey Medical School, Newark, NJ, USA Pathology was Email: [email protected] launched in 1988, changed its name Coordinating Editor to Cellular Oncology Marion C. Cohen, PhD, SUNY Downstate Medical Center, Brooklyn, NY, USA between 2005 and Email: [email protected] 2009 and then in Associate Editors 2010, reverted to Ulysses J. Balis, USA Richard Levenson, USA Analytical Cellular Elaine Bearer, USA Jonathan Reichner, USA Pathology: Cellular Hilary Coller, USA Thomas Ried, USA Oncology. In 2011 it Walter Giaretti, Italy Gordon W. Stamp, United Kingdom continues as Analytical Ronald H. Goldfarb, USA Ronald S. Weinstein, USA Cellular Pathology. Abstracting & Indexing Coverage Academic Source Complete, & Citation Index, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts Service (CAS), Current Contents/Clinical Medicine, Current Contents®/ Life Sciences, EBSCO Databases, Elsevier BIOBASE, Embase, Global Health, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubMed, Science Citation Index Expanded (SciSearch®), Science Citation Index® (*Wos), SciVerse Scopus, SIIC Data Bases, Ulrich’s Periodicals Directory Instructions for Authors www.iospress.com/journal/analytical-cellular-pathology Subscription Information 2012 Volumes 34-35 (12 issues) *Journal Impact Factors from Journal Citation Reports® Institutional subscription (print & online): US$2120 / €1504 Science Edition 2009, published (including postage & handling) by Thomson Reuters ©2010 Institutional subscription (online only): US$1955 / €1390 Individual subscription (online only): US$300 / €250 Breast Disease An International Journal

ISSN 0888-6008 (print) ISSN 1558-1551 (online)

The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will impact patient outcome. This research, that spans basic science, clinical medicine, epidemiology and public policy, poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also, it is important to understand the public implications of these discoveries.

Breast Disease publishes review issues devoted to in-depth analyses of the scientific and public implications of recent research on a specific problem in breast cancer. Meeting the information needs of scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer research or clinical management.

Breast Disease now also publishes unsolicited peer-reviewed articles. Topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging and social and legal issues.

Editor-in-Chief Jeffrey E. Green, MD, Bethesda, MD, USA Email: [email protected]

Founding Editor Edison T. Liu, MD, Executive Director, Genome Institute of Singapore

Abstracting & Indexing Coverage Academic Source Complete, Cancer Prevention and Control Database, Chemical Abstracts Service (CAS), EBSCO Databases, Elsevier BIOBASE, Embase, Epilepsy Education and Prevention Database, Health Education and Promotion Database, Index Medicus, MEDLINE, Prenatal Smoking Cessation Database, PubMed, SciVerse Scopus, Ulrich’s Periodicals Directory

Instructions for Authors www.iospress.com/journal/breast-disease

Subscription Information 2012 Volume 34 (4 issues) Institutional subscription (print & online): US$646 / €460 (including postage & handling) Institutional subscription (online only): US$590 / €420 Individual subscription (online only): US$175 / €150 Cancer Biomarkers

Impact Factor: 2.418*

ISSN 1574-0153 (print) ISSN 1875-8592 (online)

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the Editor- in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation, are accepted.

Editor-in-Chief Sudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USA Email: [email protected]

Associate Editors William E. Grizzle, MD, PhD Anna Lokshin, PhD Attila T. Lorincz, PhD Paola Muti, MD Harvey Pass, MD Tesshi Yamada, MD, PhD

Abstracting & Indexing Coverage Academic Source Complete, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts Service (CAS), Elsevier BIOBASE, Embase, EMBIO, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubsHub, Science Citation Index Expanded (SciSearch®), SciVerse Scopus, Ulrich’s Periodicals Directory

Instructions for Authors www.iospress.com/journal/cancer-biomarkers

Subscription Information 2012 Volumes 11-12 (12 issues) Institutional subscription (print & online): US$1653 / €1180 (including postage & handling) Institutional subscription (online only): US$1485 / €1060 Individual subscription (online only): US$300 / €250

*Journal Impact Factors from Journal Citation Reports® Science Edition 2010, published by Thomson Reuters ©2011 Disease Markers

Impact Factor: 1.723*

ISSN 0278-0240 (print) ISSN 1875-8630 (online)

Disease Markers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including:

• Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA- sequences) • Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states • Amplification of knowledge about existing markers • Family studies of markers in disease • New techniques for identification and/or isolation of important marker molecules • Use of monoclonal antibodies for the definition of molecular structures associated with disease markers • Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms • Identification of markers identifying malignantly transformed neoplastic cells

Editor-in-Chief Sudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USA Email: [email protected]

Associate Editor Michele Carbone, MD, PhD

Abstracting & Indexing Coverage Academic Source Complete, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, CAB Abstracts, Chemical Abstracts Service (CAS), CSA Illumina, EBSCO Databases, Elsevier BIOBASE, Embase, EMBIO, Global Health, Index Copernicus, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubMed, Reference Update®, Science Citation Index Expanded (SciSearch®), SciVerse Scopus, Ulrich’s Periodicals Directory

Instructions for Authors www.iospress.com/journal/disease-markers

Subscription Information 2012 Volumes 32-33 (12 issues) Institutional subscription (print & online): US$2318 / €1605 *Journal Impact Factors from Journal Citation Reports® (including postage & handling) Science Edition 2010, published Institutional subscription (online only): US$2150 / €1485 by Thomson Reuters ©2011 Individual subscription (online only): US$300 / €250 Human Antibodies

ISSN 1093-2607 (print) ISSN 1875-869X (online)

Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, are also featured.

Editor-in-Chief Mark C. Glassy, PhD, Integrated Medical Sciences Association Foundation, San Diego, CA, USA Email: [email protected]

Abstracting & Indexing Coverage Academic Source, Article@inist, Biological Abstracts, BIOSIS Previews, Cambridge Scientific Abstracts, Chemical Abstracts Service (CAS), CSA Illumina, EBSCO Databases, Embase, Index Medicus, MEDLINE, PubMed, SciVerse Scopus, SUBIS, Ulrich’s Periodicals Directory

Instructions for Authors www.iospress.com/journal/human-antibodies

Subscription Information 2012 Volume 21 (4 issues) Institutional subscription (print & online): US$796 / €570 (including postage & handling) Institutional subscription (online only): US$740 / €530 Individual subscription (online only): US$185 / €155 Also of interest

Translational Pathology of Early Cancer

Editors: S. Srivastava and W.E. Grizzle March 2012, 568 pp., hardcover ISBN 978-1-61499-023-9 (print) ISBN 978-1-61499-024-6 (online) Price: US$239 / €156

The visual pathologic features of tumors have always been the critical parameters in determining tumor type, however, over the last several decades molecular analysis of tumors has played an increasing role in the diagnostic pathology of tumors. Thus, “molecular pathology” has gradually emerged as a discipline in pathology which exploits the use of nucleic acid based techniques.

The purpose of this Handbook is to discuss the principles and the application of selected existing methods of molecular pathology and its use in the detection of early cancer. It describes the molecular changes that characterize preinvasive neoplastic lesions, molecular targets for early detection, validation of molecular targets and areas of new diagnostic technology that show promise either for early detection of neoplasias or other medically important uses in cancer prevention and care. The book describes recent advances in proteomics, metabolomics, stem cells research, micro RNA and other posttranslational molecular modifications; all these will serve the pressing needs in the development of the practice of personalized medicine.

The book is divided into three sections that follow a sequence from basic mechanisms of tumor development, through the molecular and biological abnormalities found in common types of cancers, to the technologies that are most applicable to detecting these biologic alterations in precancerous lesions. Each chapter discusses the scientific underpinnings of the evolution and progression of tumors in order to enable clinicians and other professionals who manage cancer patients to better understand the disease at the molecular and genetic levels.

Follow us on Twitter: @IOSPress_STM PUBLISH YOUR RESEARCH RESULTS OR CONFERENCE PROCEEDINGS WITH IOS PRESS

IOS Press welcomes proposals for publishing textbooks, edited volumes, handbooks, conference proceedings, monographs and dissertations.

Proposals can be sent to [email protected], or you can fill in the form in the Authors’ Corner on www.iospress.com.

Why publish with IOS Press?

High visibility of the publication · Book is submitted to relevant scientific indexes · Inclusion in Google Book Search

Lenient copyright policy · Authors retain copyright to their articles · Manuscript versions may be posted freely on personal websites

Print and online publication · DOI registration for all articles · All book articles available as separately downloadable items · High quality print publication produced in the Netherlands

Clear guidelines for authors and editors · Guidelines can be found through the Authors’ Corner on www.iospress.com · Author templates for LaTeX or MSWord at author’s choice

Personal approach · Dedicated team of skilled publishing professionals · All books receive individual attention · Flexibility

Worldwide marketing and distribution · Books are available through all major booksellers including Amazon and Barnes & Noble · Sales offices and representatives on all continents

Permanent archiving is guaranteed through an arrangement with the Dutch Royal Library

To explore IOS Press books and the Authors’ Corner, visit www.iospress.com.

For ebooks, go to www.booksonline.iospress.com ABOUT IOS PRESS

For over 20 years IOS Press has been serving the scientific community worldwide. IOS Press publishes about 120 new books and 100 international journals each year covering topics ranging from computer science and mathematics to medicine and the natural sciences.

All titles in this catalogue are available online as well as in print. Many titles are covered in the most important abstracting databases, such as Thomson Reuters / ISI, MEDLINE and SciVerse Scopus.

Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008.

IOS Press journals are available through the highly-regarded MetaPress platform (http://iospress.metapress.com). ORDER FORM

Order Online at www.iospress.com Select the title of your choice and click subscribe now. No shipping costs will be charged.

Yes, I would like to order…

Please send me the following journals: ______

Please send me the following book: Translational Pathology of Early Cancer

Please bill me (postage and handling charges will be added)

Please charge my credit card: American Express Euro/MasterCard Visa

Card #: ______

Security Code: ______Exp. Date: ______

VAT #: ______

Name: ______

Address: ______

City/State: ______Zip/Postal Code: ______Country: ______

Email: ______Fax: ______

Signature: ______Date: ______

If you would like to order directly from IOS Press, please use one of the addresses below: IOS Press, Inc. IOS Press IOS Press 4502 Rachael Manor Drive Nieuwe Hemweg 6B c/o Accucoms US, Inc. Fairfax, VA 22032 1013 BG Amsterdam For North America Sales and USA The Netherlands Customer Service (Journals only) Tel: +1 703 323 5600 Tel: +31 20 688 3355 West Point Commons, Suite 201 Fax: +1 703 323 3668 Fax: +31 20 687 0019 Lansdale, PA 19446 [email protected] Email: [email protected] USA (Books only) Tel: +1 866 855 8967 Fax: +1 215 660 5042 Email: [email protected] Order from your local bookseller or usual supplier.

2/12 www.iospress.com